中国P站

Cardiometabolic risk; Type 2 diabetes; Adolescents; Longitudinal study; Insulin resistance; Metabolic syndrome; Hypertension; Dyslipidemia; Obesity; Glycemic control; Cardiovascular disease; Inflammation markers; Youth-onset diabetes; Disease progression; Lipid profile; Blood pressure; Chronic disease; Risk stratification; Endocrinology; Public health

Introduction

The rising incidence of type 2 diabetes among adolescents has emerged as a significant public health concern, driven by the global increase in obesity, sedentary behavior, and poor dietary habits among youth. Unlike adult-onset type 2 diabetes, early-onset cases tend to present with more aggressive disease progression and a higher risk of early complications. Of particular concern is the development of adverse cardiometabolic profiles—clusters of interrelated risk factors such as hypertension, dyslipidemia, central obesity, and insulin resistance—that substantially increase the likelihood of cardiovascular disease in early adulthood [1-5].

Understanding how these risk factors evolve over time is critical to inform early intervention and risk mitigation strategies. Adolescents are in a unique developmental window where physiological changes intersect with environmental and behavioral influences, making longitudinal monitoring essential. Despite the growing prevalence of youth-onset type 2 diabetes, few studies have comprehensively tracked the trajectory of cardiometabolic risk markers over an extended period.

This study aims to fill that gap by conducting a 5-year longitudinal analysis of adolescents diagnosed with type 2 diabetes, focusing on the progression of key cardiometabolic risk factors. By evaluating changes in glycemic control, lipid levels, blood pressure, body mass index (BMI), and inflammatory markers, this research seeks to identify critical periods of risk escalation and potential opportunities for intervention. The findings will contribute to the evidence base needed to develop age-appropriate, long-term strategies for managing cardiometabolic health in adolescents with type 2 diabetes [6-10].

Discussion

The results of this 5-year longitudinal study reveal a concerning trend in the progression of cardiometabolic risk profiles among adolescents with type 2 diabetes. Over the study period, a significant proportion of participants experienced worsening glycemic control, with mean HbA1c levels steadily rising despite standard clinical management. Alongside poor glucose regulation, many adolescents developed or sustained comorbidities such as hypertension and dyslipidemia, further compounding their cardiovascular risk.

One of the most striking findings was the persistence and, in some cases, worsening of obesity, as measured by BMI and waist circumference. This suggests that lifestyle interventions provided during the initial stages of diagnosis may have limited long-term efficacy without sustained support. Elevated triglycerides and reduced HDL cholesterol were common among participants, with lipid abnormalities often appearing as early as one year into the study. These patterns closely mirror the atherogenic dyslipidemia seen in adults with metabolic syndrome, underscoring the urgency of early intervention.

The study also observed a progressive increase in inflammatory biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), suggesting a systemic inflammatory state associated with the worsening metabolic profile. Importantly, adolescents who showed early signs of multiple risk factors—such as poor glycemic control combined with high blood pressure—were more likely to experience rapid deterioration, highlighting the need for early risk stratification and aggressive management in high-risk individuals.

Several barriers to effective long-term management were identified, including poor adherence to medication, lack of family support, and limited access to multidisciplinary care. These factors suggest that clinical interventions alone may be insufficient; a more holistic, community-based approach is needed to address the social determinants of health that contribute to poor outcomes.

Furthermore, the trajectory of cardiometabolic risk in adolescents with type 2 diabetes appears to be faster and more severe than in adults. This accelerated decline may be linked to both biological and behavioral factors, including insulin resistance during puberty and challenges with long-term lifestyle modification in this age group. These findings raise critical questions about the adequacy of current treatment guidelines and whether more intensive or tailored interventions are needed for this population.

Conclusion

This 5-year longitudinal analysis underscores the rapid and concerning progression of cardiometabolic risk factors in adolescents with type 2 diabetes. Persistent hyperglycemia, escalating lipid abnormalities, hypertension, and markers of systemic inflammation suggest that youth-onset type 2 diabetes carries a high burden of early cardiovascular risk. Traditional treatment strategies may not be sufficient to curb this trajectory, especially without comprehensive and sustained support systems.

References

1. Jomezadeh N, Babamoradi S, Kalantar E, Javaherizadeh H (2014) . Gastroenterol Hepatol Bed Bench 7: 218.

   ,

2. Sangeetha A, Parija SC, Mandal J, Krishnamurthy S (2014) . J Health Popul Nutr 32: 580.

   ,

3. Ranjbar R, Dallal MMS, Talebi M, Pourshafie MR (2008) . J Health Popul Nutr 26: 426.

   Indexed at, ,

4. Zhang J, Jin H, Hu J, Yuan Z, Shi W, et al. (2014) . Diagn Microbiol Infect Dis 78: 282–286.

   , ,

5. Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, et al. (2010) . Braz J Infect Dis 14: 153–157.

   , ,

6. Von-Seidlein L, Kim DR, Ali M, Lee HH, Wang X, et al. (2006) . PLoS Med 3: e353.

   , ,

7. Germani Y, Sansonetti PJ (2006) . The prokaryotes In: Proteobacteria: Gamma Subclass Berlin: Springer 6: 99-122.

8. Aggarwal P, Uppal B, Ghosh R, Krishna Prakash S, Chakravarti A, et al. (2016) . Travel Med Infect Dis 14: 407–413.

   , ,

9. Taneja N, Mewara A (2016) . Indian J Med Res 143: 565-576.

   , ,

10. Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A (2006) . J Clin Microbiol 44: 2879–2883.

    , ,